Condor’s AI-powered Financial Intelligence Platform consolidates clinical, operational, and financial data using proprietary clinical and financial ontologies to map relationships between protocols, site activity, vendor contracts, and accounting rules. The platform includes three core modules—Connect (data integration), Compass (forecasting and scenario modeling), and Copilot (automation of accruals, reconciliations, and month-end close). Condor manages over $19 billion in R&D spend and counts customers such as Acadia Pharmaceuticals, Alumis Therapeutics, BridgeBio Pharma, and Madrigal Pharmaceuticals. Customers report better than 90% forecast accuracy, 70% faster month-end close, and an average of 30% budget savings. The company plans to expand enterprise capabilities and scale engineering, product, design, sales, and customer success teams using proceeds from its Series A. Condor was founded by Jennifer Kyle and is headquartered in San Diego.

Total raised

$24M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2026